Development and Validation of the Depression Inventory for Type 1 Diabetes (DID-1)

dc.contributor.authorCarreira, Monica
dc.contributor.authorRuiz de Adana, Maria Soledad
dc.contributor.authorDominguez, Marta
dc.contributor.authorValdes, Sergio
dc.contributor.authorAlmaraz, Maria Cruz
dc.contributor.authorOlveira, Gabriel
dc.contributor.authorAnarte, Maria Teresa
dc.contributor.authoraffiliation[Carreira, Monica] Univ Malaga, Fac Psychol, Dept Personal Assessment & Psychol Treatment, Campus Teatinos, Malaga 29071, Spain
dc.contributor.authoraffiliation[Anarte, Maria Teresa] Univ Malaga, Fac Psychol, Dept Personal Assessment & Psychol Treatment, Campus Teatinos, Malaga 29071, Spain
dc.contributor.authoraffiliation[Carreira, Monica] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Ruiz de Adana, Maria Soledad] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Dominguez, Marta] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Valdes, Sergio] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Almaraz, Maria Cruz] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Olveira, Gabriel] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Anarte, Maria Teresa] Inst Invest Biomed Malaga IBIMA, Malaga 29010, Spain
dc.contributor.authoraffiliation[Ruiz de Adana, Maria Soledad] Reg Univ Hosp, Clin Management Unit Endocrinol & Nutr, Malaga 29010, Spain
dc.contributor.authoraffiliation[Dominguez, Marta] Reg Univ Hosp, Clin Management Unit Endocrinol & Nutr, Malaga 29010, Spain
dc.contributor.authoraffiliation[Valdes, Sergio] Reg Univ Hosp, Clin Management Unit Endocrinol & Nutr, Malaga 29010, Spain
dc.contributor.authoraffiliation[Almaraz, Maria Cruz] Reg Univ Hosp, Clin Management Unit Endocrinol & Nutr, Malaga 29010, Spain
dc.contributor.authoraffiliation[Olveira, Gabriel] Reg Univ Hosp, Clin Management Unit Endocrinol & Nutr, Malaga 29010, Spain
dc.contributor.authoraffiliation[Ruiz de Adana, Maria Soledad] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain
dc.contributor.authoraffiliation[Dominguez, Marta] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain
dc.contributor.authoraffiliation[Valdes, Sergio] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain
dc.contributor.authoraffiliation[Almaraz, Maria Cruz] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain
dc.contributor.authoraffiliation[Olveira, Gabriel] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain
dc.date.accessioned2025-01-07T12:20:48Z
dc.date.available2025-01-07T12:20:48Z
dc.date.issued2021-12-01
dc.description.abstractPeople with type 1 diabetes (T1D) are more likely to have depression than the general population and their prognosis is worse. Unfortunately, the characteristics of persons with T1D lead to inadequate screening for depression in this population. To aid in the detection of depression in this population, this study was undertaken to develop a depressive symptoms assessment instrument specific to patients with T1D and to examine its psychometric properties. A total of 207 people with T1D participated in this study. The reliability of the new scale was assessed using Cronbach's alpha and the Spearman-Brown split-half coefficient. The Depression Inventory for type 1 Diabetes (DID-1), composed of 45 items on a Likert scale (1-7), shows high internal and temporal consistency, as well as adequate concurrent, convergent and discriminant validity. Factor analysis identified 7 factors (Symptoms of depression, Diminished interest, Hopelessness and dissatisfaction, Guilt, Fear, frustration and irritability, Defenselessness, and Interference in daily life) that explained 61.612% of the total variability. The cut-off score for diagnosis was set at 155 points. It was concluded that the DID-1 scale is a reliable, valid and useful tool for the assessment of depressive symptoms, eliminating the bias of other nonspecific diabetes scales.
dc.identifier.doi10.3390/ijerph182312529
dc.identifier.essn1660-4601
dc.identifier.pmid34886259
dc.identifier.unpaywallURLhttps://www.mdpi.com/1660-4601/18/23/12529/pdf?version=1638340842
dc.identifier.urihttps://hdl.handle.net/10668/24495
dc.identifier.wosID734840600001
dc.issue.number23
dc.journal.titleInternational journal of environmental research and public health
dc.journal.titleabbreviationInt. j. environ. res. public health
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.publisherMdpi
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjecttype 1 diabetes
dc.subjectdepression
dc.subjectdepressive symptoms
dc.subjectscale development
dc.subjectDepression Inventory for type 1 Diabetes
dc.subjectAnxiety disorders
dc.subjectSelf-care
dc.subjectSymptoms
dc.subjectAdults
dc.subjectPrevalence
dc.subjectComplications
dc.subjectManagement
dc.subjectDistress
dc.subjectPeople
dc.subjectAssociation
dc.titleDevelopment and Validation of the Depression Inventory for Type 1 Diabetes (DID-1)
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number18
dc.wostypeArticle

Files